Pharmalot Ed Silverman Pharmalot, Pharmalittle: Merck drug wins FDA nod as first-line lung cancer treatment
Pharmalot Ed Silverman Pharmalot, Pharmalittle: Alkermes depression drug now looks promising, but will FDA bite?
Pharmalot Ed Silverman Pharmalot, Pharmalittle: FDA staff questions effectiveness of Merck antibiotic
Pharmalot Ed Silverman Gilead won’t have to pay $200 million in patent case because Merck lawyer lied
Pharmalot Ed Silverman Pharmalot, Pharmalittle: Investors tell pharma to ‘take control’ of the pricing debate
The Pharmalot View Ed Silverman Big drug maker presses for money-back guarantee that its science will work
Pharmalot Ed Silverman Pharmalot, Pharmalittle: China probing drug and device makers for antitrust violations
Pharmalot Ed Silverman Switching to newest HPV vaccine can save billions in health care costs, study says